Molecular Docking Study of Phthalimide Derivatives as Non-nucleoside HIV-1 Reverse Transcriptase Inhibitor

Molecular Docking Study of Phthalimide Derivatives as Non-nucleoside HIV-1 Reverse Transcriptase Inhibitor

The molecular docking approach was used to determine the binding affinities and the interactions of Mycobacterium tuberculosis dihydrofolate reductase (mtbDHFR) in complex with 2, 4-diaminopyrimidines analogues (PYR analogous). This approach can classify compounds into low and high affinity agents w...

Full description

Saved in:

Bibliographic Details
Main Authors:	Pimonluck Sittikornpaiboon, Pisanu Toochinda, Chawanee Thongpanchang, Ubolsree Leartsakulpanich, Luckhana Lawtrakul
Format:	บทความวารสาร
Language:	English
Published:	Science Faculty of Chiang Mai University 2019
Online Access:	http://it.science.cmu.ac.th/ejournal/dl.php?journal_id=7351 http://cmuir.cmu.ac.th/jspui/handle/6653943832/63791
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	Chiang Mai University
Language:	English

Similar Items

Molecular Docking Study of Phthalimide Derivatives as Non-nucleoside HIV-1 Reverse Transcriptase Inhibitor
by: Chirattikan Maicheen, et al.
Published: (2019)

Molecular docking study of phthalimide derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitor
by: Chirattikan Maicheen, et al.
Published: (2018)

Docking study on phthalimide derivatives : HIV-1 reverse transcriptase inhibitors
by: Jiraporn Ungwitayatorn, et al.
Published: (2010)

Synthesis and HIV-1 reverse transcriptase inhibitory activity of non-nucleoside phthalimide derivatives
by: Jiraporn Ungwitayatorn, et al.
Published: (2018)

3D-QSAR studies on phthalimide derivatives as HIV-1 reverse transcriptase inhibitors
by: Weerasak Samee, et al.
Published: (2010)

Quantitative structure-activity relationship study on phthalimide derivatives as HIV-1 reverse transcriptase inhibitors
by: Jiraporn Ungwtayatorn, et al.
Published: (2010)

Synthesis, evaluation and molecular modeling of chromone derivatives as HIV-1 protease inhibitors and molecular modeling of phthalimide derivatives as HIV-1 reverse transcriptase inhibitors
by: Weerasak Samee
Published: (2023)

Multi-drug resistant HIV-1 reverse transcriptase genotype in children treated with dual nucleoside reverse transcriptase inhibitors (NRTIs)
by: Chulapan Engchanil, et al.
Published: (2018)

Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors
by: Sunee Sirivichayakul, et al.
Published: (2018)

Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Linda Aurpibul, et al.
Published: (2018)

Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Linda Aurpibul, et al.
Published: (2018)

Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Aurpibul L., et al.
Published: (2014)

Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Aurpibul L., et al.
Published: (2014)

Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Linda Aurpibul, et al.
Published: (2018)

Effects of Zidovudine, nucleoside reverse transcriptase inhibitor, on the development of Danio rerio (Zebrafish) embryos
by: Nunag, Lincoln Chua
Published: (2013)

Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia
by: David C. Boettiger, et al.
Published: (2018)

Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia
by: Boettiger D., et al.
Published: (2017)

HIV-1 Drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Somnuek Sungkanuparph, et al.
Published: (2018)

Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitorbased regimens in Asian HIV-infected children
by: Torsak Bunupuradah, et al.
Published: (2018)

Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitorbased regimens in Asian HIV-infected children
by: Torsak Bunupuradah, et al.
Published: (2018)

Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitorbased regimens in Asian HIV-infected children
by: Torsak Bunupuradah, et al.
Published: (2018)

Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in thai hiv-infected children aged two years or less
by: Thanyawee Puthanakit, et al.
Published: (2018)

Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in thai hiv-infected children aged two years or less
by: Thanyawee Puthanakit, et al.
Published: (2018)

Recovery from lipodystrophy in HIV-infected children after substitution of stavudine with zidovudine in a non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Linda Aurpibul, et al.
Published: (2018)

Recovery From Lipodystrophy in HIV-infected Children After Substitution of Stavudine With Zidovudine in a Non-nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy
by: Aurpibul L., et al.
Published: (2014)

Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in thai hiv-infected children aged two years or less
by: Puthanakit T., et al.
Published: (2014)

HIV-1 genotype after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and virological response after resumption of the same regimen
by: Somnuek Sungkanuparph, et al.
Published: (2018)

Etravirine and rilpivirine resistance in HIV-1 subtype CRF01-AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens
by: Torsak Bunupuradah, et al.
Published: (2018)

HIV-1 reverse transcriptase inhibitors from family zingiberaceae
by: Kasem Sookkongwaree
Published: (2007)

Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral Therapy
by: Podjanee Jittamala, et al.
Published: (2018)

Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral Therapy
by: Podjanee Jittamala, et al.
Published: (2018)

Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral Therapy
by: Jittamala P., et al.
Published: (2014)

Rapid CD4 decline after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy in a resource-limited setting
by: Somnuek Sungkanuparph, et al.
Published: (2018)

FRET-based assay to screen inhibitors of HIV-1 reverse transcriptase and nucleocapsid protein
by: Sharma, Kamal K, et al.
Published: (2023)

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudine
by: Michele W. Tang, et al.
Published: (2018)

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudine
by: Michele W. Tang, et al.
Published: (2018)

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudine
by: Tang M.W., et al.
Published: (2014)

A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients
by: Jintanat Ananworanich, et al.
Published: (2018)

Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy
by: Thanyawee Puthanakit, et al.
Published: (2018)

Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy
by: Thanyawee Puthanakit, et al.
Published: (2018)